SCHEMBL17508360

SCHEMBL17508360

Clc1nc(-c2cccc(-c3ccccc3)c2)c2cccnc2n1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 8/20 0.44
DHODH Q02127 1/20 0.43
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GLA P06280 1/20 0.41
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
OPRK1 P41145 1/20 0.38
MAPK13 O15264 1/20 0.38
GCGR P47871 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38
TDO2 P48775 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15860220 0.89 DHODH (0.52) ABCG2DHODHALDH1A1KDM4ELMNA
SCHEMBL4146794 0.89 KDM4E (0.52) ABCG2DHODHALDH1A1KDM4ELMNA
SCHEMBL15860269 0.82 HTR2B (0.44) ABCG2DHODHALDH1A1KDM4ELMNA
SCHEMBL15003550 0.82 DHODH (0.43) ABCG2DHODHTDO2
SCHEMBL17522835 0.81 ALDH1A1 (0.42) ALDH1A1KDM4ELMNAMAPTHPGD
SCHEMBL15538738 0.80 KDM4E (0.61) ALDH1A1KDM4ELMNAMAPTHPGD
SCHEMBL16475867 0.78 KDM4E (0.64) ALDH1A1KDM4ELMNAMAPTHPGD
SCHEMBL16231237 0.77 ABCG2 (0.47) ABCG2DHODHSMN1; SMN2
SCHEMBL15003523 0.77 ABCG2 (0.47) ABCG2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL20659817 0.76 KDM4E (0.42) ABCG2DHODHALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE AHR, CDYL, SLC18A1 ABCG2 125/4885DHODH 2327/4885ALDH1A1 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.